Literature DB >> 26873988

FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.

Estelle Marion1, Ulrich Jarry2, Camille Cano3, Caroline Savary4, Céline Beauvillain5, Marie Robbe-Saule3, Laurence Preisser2, Frederic Altare6, Yves Delneste5, Pascale Jeannin5, Laurent Marsollier3.   

Abstract

Buruli ulcer, a debilitating disease, is caused by Mycobacterium ulcerans. The incidence of this neglected tropical disease is steadily increasing. As a rule, without treatment, skin ulcers occur and a lengthy healing process may be observed associated with severe functional disabilities. Mouse models are already available to study establishment of lesions or evaluation of therapy but a lack of a suitable animal model, mimicking all clinical stages, in particular the healing process, remains an obstacle to understand the pathophysiology of M. ulcerans infection. M. ulcerans was s.c. inoculated in three consanguine mouse strains, that is, BALB/c and C57BL/6, classically used to study mycobacterial infection, and FVB/N. Strikingly, FVB/N mice, although as sensitive as all other mouse strains with respect to M. ulcerans infection, presented a spontaneous healing after the ulcerative phase despite stable bacterial load, and mycolactone toxin was not detected in the healed tissues. The spontaneous healing process was accompanied by an activation of the innate immune system. The adaptive response initiated by FVB/N mice was not involved in the healing process and did not confer protection against M. ulcerans. Our work highlights the importance of innate immune responses to control M. ulcerans infection. This in vivo model of M. ulcerans infection now paves the way for new avenues of research toward the elucidation of critical stages of this disease, such as the characterization of the regulation of mycolactone production, a better understanding of the pathophysiology of M. ulcerans infection, and the development of new therapeutic strategies.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26873988     DOI: 10.4049/jimmunol.1502194

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Lactation-Based Maternal Educational Immunity Crosses MHC Class I Barriers and Can Impart Th1 Immunity to Th2-Biased Recipients.

Authors:  Mrinal K Ghosh; H Konrad Muller; Ameae M Walker
Journal:  J Immunol       Date:  2017-07-26       Impact factor: 5.422

2.  Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.

Authors:  Brendon Y Chua; Timothy P Stinear; Kirstie M Mangas; Andrew H Buultjens; Jessica L Porter; Sarah L Baines; Estelle Marion; Laurent Marsollier; Nicholas J Tobias; Sacha J Pidot; Kylie M Quinn; David J Price; Katherine Kedzierska; Weiguang Zeng; David C Jackson
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

3.  Drug Efficacy Testing in the Mouse Footpad Model of Buruli Ulcer.

Authors:  Paul J Converse; Deepak V Almeida; Eric L Nuermberger
Journal:  Methods Mol Biol       Date:  2022

4.  Conditions for Handling and Optimal Storage of Mycolactone.

Authors:  Jessica Z Kubicek-Sutherland; Basil I Swanson; Harshini Mukundan
Journal:  Methods Mol Biol       Date:  2022

5.  High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice.

Authors:  Kirstie M Mangas; Nicholas J Tobias; Estelle Marion; Jérémie Babonneau; Laurent Marsollier; Jessica L Porter; Sacha J Pidot; Chinn Yi Wong; David C Jackson; Brendon Y Chua; Timothy P Stinear
Journal:  PeerJ       Date:  2020-08-07       Impact factor: 2.984

6.  An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans.

Authors:  Marie Robbe-Saule; Jérémie Babonneau; Odile Sismeiro; Laurent Marsollier; Estelle Marion
Journal:  Front Microbiol       Date:  2017-03-24       Impact factor: 5.640

7.  Understanding the Significance of Biochemistry in the Storage, Handling, Purification, and Sampling of Amphiphilic Mycolactone.

Authors:  Jessica Z Kubicek-Sutherland; Dung M Vu; Aaron S Anderson; Timothy C Sanchez; Paul J Converse; Ricardo Martí-Arbona; Eric L Nuermberger; Basil I Swanson; Harshini Mukundan
Journal:  Toxins (Basel)       Date:  2019-04-04       Impact factor: 4.546

8.  Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway.

Authors:  Jeremy Manry; Quentin B Vincent; Christian Johnson; Maya Chrabieh; Lazaro Lorenzo; Ioannis Theodorou; Marie-Françoise Ardant; Estelle Marion; Annick Chauty; Laurent Marsollier; Laurent Abel; Alexandre Alcaïs
Journal:  Commun Biol       Date:  2020-04-20

9.  Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology.

Authors:  M Foulon; M Robbe-Saule; J Manry; L Esnault; Y Boucaud; A Alcaïs; M Malloci; M Fanton d'Andon; T Beauvais; N Labarriere; P Jeannin; L Abel; J P Saint-André; A Croué; Y Delneste; I G Boneca; L Marsollier; E Marion
Journal:  PLoS Pathog       Date:  2020-12-18       Impact factor: 6.823

10.  Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone.

Authors:  Marie Robbe-Saule; Mélanie Foulon; Isabelle Poncin; Lucille Esnault; Hugo Varet; Rachel Legendre; Alban Besnard; Anna E Grzegorzewicz; Mary Jackson; Stéphane Canaan; Laurent Marsollier; Estelle Marion
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.